Navigation Links
ChemAxon and Patcore Agree Distribution of Patcore Products Beyond Japan
Date:8/21/2013

BUDAPEST, Hungary and TOKYO, August 21, 2013 /PRNewswire/ --

ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and Patcore, a leading cheminformatics software and service company for pharmaceutical and life science industries, have agreed terms for the distribution of Patcore's CRAIS series of products globally excluding Japan.

Patcore's CRAIS product series are a set of innovative cheminformatics applications covering many common processes in life science research, including: compound registration, assay management, data browsing, collaborative interfaces, structure design and controlled substance compliance.

CRAIS Series

  • Checker - Controlled substances check system to reduce your daily compliance workload.
  • Transformer - Generates ideas for lead optimization based on an extensive bioisosteric knowledge base.
  • Browser - Powerful, user-friendly browser for chemical and biological data to inspire ideas
  • Registration - Make your compound registration smarter and maximize the data value
  • Assay - Standardized environment to register your assay results to a corporate database

The CRAIS products are based on ChemAxon's cheminformatics toolkits and offer users an "off the shelf" solution for common RnD processes, especially where high performance and integration within larger systems are essential.

About ChemAxon
ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries.  With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions that power modern cheminformatics and chemical communication.  The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.

About Patcore Inc.

Patcore is based in TOKYO, providing cheminformatics software and services for Pharmaceutical and life science industries. Patcore was founded in 2003 and signed with ChemAxon in 2005 as an exclusive partner in Japan. Patcore successfully developed CRAIS series using ChemAxon technologies to help users to manage chemical and biological data more efficiently. These products are well accepted by many clients and Patcore has provided them for 15 of the top 20 pharmaceutical companies in Japan to date.


'/>"/>
SOURCE ChemAxon
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pearson Adds ChemAxons Suite of Chemistry Tools to MasteringChemistry Products
2. ChemAxons Chemicalize.org Extends PubChem Database With Crowd-Sourced Chemistry From the Web
3. ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
4. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
5. Schrödinger and ChemAxon Extend Partnership
6. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
7. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
8. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
9. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
10. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
11. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):